UPPSALA, Sweden, Oct. 7, 2025 /PRNewswire/ -- Beactica Therapeutics AB, the Swedish precision medicine company, today announced that it has conducted a first scientific advisory meeting with the Swedish Medical Products Agency regarding the drug candidate BEA-17. Specifically, the...
Hence then, the article about beactica conducts first advisory meeting with the swedish medical products agency regarding the development of bea 17 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Beactica conducts first advisory meeting with the Swedish Medical Products Agency regarding the development of BEA-17 )
Also on site :
- Obama Blames Larry David For 2014 Tan Suit Debacle In ‘Life, Larry & the Pursuit of Unhappiness’ Finale
- Sports Legend Roger Craig, Who Made NFL History, Reveals Dementia Diagnosis: 'This Doesn't Define Me'
- This nuclear startup and Halliburton repurposed oil-drilling tech in a bid to solve America’s radioactive waste problem